Viatris Inc. (VTRS) Financial Ratios
23 years of historical data (2003–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
↑
N/A
—
5yr avg: 8.51
30Y Low6.9·High18.2
P/FCF
↑
9.48
↑+46% vs avg
5yr avg: 6.52
30Y Low5.4·High63.3
P/B Ratio
↑
1.27
↑+64% vs avg
5yr avg: 0.77
30Y Low0.5·High7.0
ROE
↓
-21.1%
↑-430% vs avg
5yr avg: -4.0%
30Y Low-72%·High30%
Debt/EBITDA
↓
N/A
—
5yr avg: 4.90
30Y Low0.0·High13.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
VTRS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Viatris Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 9.5x P/FCF, 46% above the 5-year average of 6.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $18.4B | $14.6B | $14.9B | $13.1B | $13.5B | $16.4B | $11.3B | $10.4B | $14.1B | $22.7B | $19.9B |
| Enterprise Value | $31.5B | $27.7B | $28.4B | $30.5B | $31.8B | $39.0B | $36.6B | $22.8B | $27.5B | $37.1B | $34.3B |
| P/E Ratio → | -5.32 | — | — | 239.07 | 6.51 | — | — | 670.00 | 40.10 | 32.55 | 41.47 |
| P/S Ratio | 1.28 | 1.02 | 1.01 | 0.85 | 0.83 | 0.91 | 0.94 | 0.90 | 1.23 | 1.91 | 1.79 |
| P/B Ratio | 1.27 | 0.99 | 0.80 | 0.64 | 0.64 | 0.80 | 0.49 | 0.87 | 1.16 | 1.71 | 1.79 |
| P/FCF | 9.48 | 7.52 | 7.52 | 5.62 | 5.40 | 6.52 | 20.46 | 7.43 | 6.74 | 12.69 | 11.99 |
| P/OCF | 7.93 | 6.29 | 6.45 | 4.67 | 4.52 | 5.42 | 9.15 | 5.76 | 6.01 | 11.00 | 9.70 |
P/E links to full P/E history page with 30-year chart
VTRS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.93 | 1.93 | 1.97 | 1.96 | 2.18 | 3.06 | 1.99 | 2.41 | 3.11 | 3.10 |
| EV / EBITDA | — | — | 9.79 | 8.68 | 6.85 | 8.72 | 18.24 | 8.35 | 9.12 | 11.43 | 15.45 |
| EV / EBIT | — | — | — | 39.24 | 9.34 | — | — | 33.99 | 32.73 | 25.79 | 59.55 |
| EV / FCF | — | 14.28 | 14.38 | 13.10 | 12.68 | 15.56 | 66.44 | 16.33 | 13.17 | 20.73 | 20.72 |
VTRS Profitability
Margins and return-on-capital ratios measuring operating efficiency
Viatris Inc. earns an operating margin of -18.6%. Operating margins have compressed from 5.0% to -18.6% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -21.1% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | 35.1% | 38.2% | 41.7% | 40.0% | 31.2% | 31.8% | 33.9% | 35.0% | 40.2% | 42.4% |
| Operating Margin | -18.6% | -18.6% | 0.1% | 5.0% | 9.9% | -0.2% | -1.8% | 6.2% | 7.9% | 12.1% | 6.3% |
| Net Profit Margin | -24.6% | -24.6% | -4.3% | 0.4% | 12.8% | -7.1% | -5.6% | 0.1% | 3.1% | 5.8% | 4.3% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -21.1% | -21.1% | -3.2% | 0.3% | 10.0% | -5.8% | -3.8% | 0.1% | 2.8% | 5.7% | 4.6% |
| ROA | -8.9% | -8.9% | -1.4% | 0.1% | 4.0% | -2.2% | -1.4% | 0.1% | 1.0% | 2.0% | 1.7% |
| ROIC | -6.7% | -6.7% | 0.0% | 1.5% | 2.9% | -0.1% | -0.4% | 2.1% | 2.5% | 4.0% | 2.5% |
| ROCE | -7.5% | -7.5% | 0.0% | 1.8% | 3.7% | -0.1% | -0.5% | 2.7% | 3.1% | 4.9% | 2.9% |
VTRS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $13.1B ($14.4B total debt minus $1.3B cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.98 | 0.98 | 0.77 | 0.90 | 0.93 | 1.14 | 1.14 | 1.09 | 1.14 | 1.10 | 1.39 |
| Debt / EBITDA | — | — | 4.93 | 5.24 | 4.21 | 5.22 | 13.05 | 4.73 | 4.58 | 4.52 | 6.96 |
| Net Debt / Equity | — | 0.89 | 0.73 | 0.85 | 0.87 | 1.11 | 1.10 | 1.05 | 1.10 | 1.08 | 1.30 |
| Net Debt / EBITDA | — | — | 4.67 | 4.96 | 3.93 | 5.07 | 12.62 | 4.55 | 4.45 | 4.43 | 6.51 |
| Debt / FCF | — | 6.76 | 6.86 | 7.47 | 7.28 | 9.04 | 45.98 | 8.91 | 6.43 | 8.03 | 8.74 |
| Interest Coverage | -5.65 | -5.65 | 0.02 | 1.34 | 2.73 | -0.05 | -0.42 | 1.38 | 1.67 | 2.69 | 1.54 |
VTRS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Viatris Inc.'s current ratio of 5.06x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.99x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 1.67x to 5.06x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.06 | 5.06 | 1.65 | 1.67 | 1.58 | 1.10 | 1.22 | 1.21 | 1.39 | 1.13 | 1.49 |
| Quick Ratio | 2.99 | 2.99 | 0.98 | 1.22 | 1.05 | 0.70 | 0.70 | 0.73 | 0.83 | 0.73 | 1.01 |
| Cash Ratio | 0.68 | 0.68 | 0.19 | 0.15 | 0.22 | 0.09 | 0.10 | 0.10 | 0.10 | 0.06 | 0.21 |
| Asset Turnover | — | 0.38 | 0.36 | 0.32 | 0.33 | 0.33 | 0.19 | 0.37 | 0.35 | 0.33 | 0.32 |
| Inventory Turnover | 2.32 | 2.32 | 2.37 | 2.59 | 2.77 | 3.09 | 1.49 | 2.85 | 2.88 | 2.80 | 2.60 |
| Days Sales Outstanding | — | 77.37 | 87.22 | 95.60 | 92.98 | 87.06 | 148.00 | 97.08 | 77.14 | 97.26 | 99.36 |
VTRS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Viatris Inc. returns 5.7% to shareholders annually — split between a 3.0% dividend yield and 2.7% buyback yield.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.0% | 3.9% | 3.9% | 4.4% | 4.3% | 2.4% | — | — | — | — | — |
| Payout Ratio | — | — | — | 1052.3% | 28.0% | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 0.4% | 15.4% | — | — | 0.1% | 2.5% | 3.1% | 2.4% |
| FCF Yield | 10.5% | 13.3% | 13.3% | 17.8% | 18.5% | 15.3% | 4.9% | 13.5% | 14.8% | 7.9% | 8.3% |
| Buyback Yield | 2.7% | 3.4% | 1.7% | 1.9% | 0.0% | 0.1% | 0.0% | 0.0% | 3.1% | 2.2% | 0.1% |
| Total Shareholder Yield | 5.7% | 7.3% | 5.6% | 6.3% | 4.3% | 2.5% | 0.0% | 0.0% | 3.1% | 2.2% | 0.1% |
| Shares Outstanding | — | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | $601M | $517M | $517M | $537M | $521M |
Peer Comparison
Compare VTRS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 VTRSYou | $18B | -5.3 | — | 9.5 | 35.1% | -18.6% | -21.1% | -6.7% | — |
 TEVA | $42B | 30.3 | 17.8 | 36.9 | 51.8% | 12.5% | 20.7% | 7.7% | 5.5 |
 AMRX | $4B | 61.9 | — | 15.9 | 36.9% | -0.2% | 15.7% | -0.2% | — |
 PRGO | $2B | -1.2 | 7.5 | 11.6 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 |
 PFE | $151B | 19.5 | 10.7 | 16.6 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 MRK | $280B | 15.6 | 10.8 | 22.7 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 |
 ABBV | $363B | 86.5 | 15.1 | 20.4 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
 LPTX | $65M | 11.0 | — | — | — | — | 16.3% | -48.3% | — |
 MCK | $91B | 28.9 | 18.5 | 17.4 | 3.5% | 1.2% | — | 540.6% | 1.5 |
 CAH | $45B | 29.7 | 16.5 | 24.4 | 3.7% | 1.0% | — | 3378.7% | 3.0 |
 CVS | $111B | 62.5 | 13.1 | 14.3 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 22 years · Updated daily
Full VTRS Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See VTRS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VTRS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VTRS vs TEVA
Side-by-side business, growth, and profitability comparison vs Teva Pharmaceutical Industries Limited.
Start ComparisonVTRS — Frequently Asked Questions
Quick answers to the most common questions about buying VTRS stock.
What is Viatris Inc.'s P/E ratio?
Viatris Inc.'s current P/E ratio is -5.3x. The historical average is 28.9x.
What is Viatris Inc.'s ROE?
Viatris Inc.'s return on equity (ROE) is -21.1%. The historical average is 3.2%.
Is VTRS stock overvalued?
Based on historical data, Viatris Inc. is trading at a P/E of -5.3x. Compare with industry peers and growth rates for a complete picture.
What is Viatris Inc.'s dividend yield?
Viatris Inc.'s current dividend yield is 3.01%.
What are Viatris Inc.'s profit margins?
Viatris Inc. has 35.1% gross margin and -18.6% operating margin.